Related Experiment Video
Updated: Apr 5, 2026
06:07
Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
8.0K
Smoking, inflammation and small cell lung cancer: recent developments.
Gerhard Hamilton1,2, Barbara Rath3
1Department of Surgery, Medical University of Vienna, 1090, Vienna, Austria. gerhard.hamilton@meduniwien.ac.at.
Wiener Medizinische Wochenschrift (1946)
|August 21, 2015
Summary
Small cell lung cancer (SCLC) involves invasive neuroendocrine tumors. Inflammation drives the spread and chemoresistance of SCLC circulating tumor cells (CTCs), explaining poor outcomes.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Small cell lung cancer (SCLC) is an aggressive neuroendocrine malignancy, accounting for 15% of lung tumors, with poor prognosis.
- SCLC is strongly linked to smoking and characterized by p53 and retinoblastoma gene inactivation.
- Circulating tumor cells (CTCs) play a crucial role in SCLC dissemination and treatment resistance.
Purpose of the Study:
- To investigate the mechanisms of tumor dissemination and chemoresistance in SCLC using an in vitro CTC model.
- To explore the role of tumor-associated macrophages (TAMs) and inflammation in SCLC progression.
- To identify molecular markers associated with SCLC invasiveness and drug resistance.
Main Methods:
- In vitro expansion of SCLC patient-derived circulating tumor cells (CTCs).
- Co-culture systems to model tumor-macrophage interactions.
- Analysis of signaling pathways, including STAT3, and marker expression (YKL-40).
Main Results:
- SCLC CTCs attract and educate immunosuppressive macrophages, facilitating tumor spread and metastasis.
- Chronic obstructive pulmonary disease (COPD)-associated inflammation enhances TAM activity.
- STAT3 activation and YKL-40 expression in SCLC CTCs correlate with drug resistance.
Conclusions:
- Inflammation-driven generation of invasive and chemoresistant SCLC CTCs underlies early dissemination and chemotherapy failure.
- Targeting TAMs and inflammatory pathways may offer novel therapeutic strategies for SCLC.
- Understanding CTC biology is critical for improving SCLC patient outcomes.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.1K
01:17Other Pulmonary Disorders
2.0K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
2.0K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
4.1K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.1K
01:20COPD: Pathogenesis and Clinical Features
2.2K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K
01:26Stress Prevention and Stress Management Techniques IV
344
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
344
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.2K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.2K